AbCellera Investor Presentation Deck slide image

AbCellera Investor Presentation Deck

CORPORATE OVERVIEW COPYRIGHT © ABCELLERA 3 THE PROBLEM LIMITED TECHNOLOGIES & FRAGMENTED APPROACHES can't keep pace with antibody drug discovery. first 50 antibodies approved by FDA took 29 years 1986 .............. next 50 antibodies took 6 years 2015 * As at May 2021. Source: Nature Reviews: FDA approves 100th monoclonal antibody product 2021* OUR SOLUTION BRING BETTER ANTIBODIES TO PATIENTS, FASTER. We deliver lead candidates in less time and with a higher probability of success.
View entire presentation